LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NYSE: PBYI), a development stage
biopharmaceutical company, announced financial results for the second
quarter ended June 30, 2014.
Unless otherwise stated, all comparisons are for the second quarter and
first half of the year 2014 compared to the second quarter and first
half of the year 2013.
Based on accounting principles generally accepted in the United States
(GAAP), Puma reported a netmore...